Healthcare Industry Joins Forces to Create New Digital Services

Twenty-one leading healthcare organisations have joined a formal partnership to tackle the nation’s healthcare challenges by accelerating growth in the digital healthcare market. Founded and led by D Health, the partnership known as ‘the Catalyst’ involves major brands Celisio (owners of Lloyds Pharmacy) and Johnson and Johnson's LifeScan. Other founding members include SMEs such as Isansys, Grey Matters and Cardio QT and healthcare providers Red House Practice Group, Just Checking and Physiomedics. Amongst others, third sector representatives Highland Hospice and Albyn Housing Society have also signed up alongside supporting organisations corporate financiers Opus, sales business Trocar and a leading consumer psychologist.

Advanced talks with potential members from other UK organisations are currently underway, whilst plans to expand the group into Europe during 2014 have progressed with the addition of Spanish cooperative, TIC Biomed to the group.

The Catalyst is set to meet for the first time in London on 5 February 2014 to discuss how it can provide new, low cost products and services for both consumer and provider markets. These could include innovations such as fitness boosting smart phone apps, blood monitoring devices, TV and phone based services for the elderly and self-management software for diabetics.

Market projections for digital healthcare vary widely, but all point to rapid growth over coming years as demand for services increases. According to a recent report conducted by Frost and Sullivan, the worldwide market for healthcare devices will garner over $509.25 billion in the next 10 years, up 87.5 per cent from $271.55 billion in the current decade.

CEO Dr Steven Dodsworth, formerly a scientist with the UK arm of the Human Genome project, leads D Health. He said: "Everyone in the healthcare industry knows what challenges lie ahead - an ageing population, more lifestyle-related ill health and growing constraints on budgets. In a nutshell, there is an increasing demand for services but fewer resources to deliver them.

"Digital healthcare has the potential to deliver popular, personalised, efficient and affordable patient services, and yet, the market isn’t growing fast enough to alleviate pressure on the NHS and local authorities.

"By creating a partnership that embodies all sections of the healthcare industry we aim to create not only new products and services but a new market dynamic based on collaboration. That way the industry can develop urgently required services that support and supplement sustainable health and care services for the future."

Ken Spooner from the Red House Group of Surgeries added: "The Catalyst offers the opportunity for developers of digital healthcare products to work with those who understand patients' needs, helping them to come up with solutions that can deliver and be part of the NHS healthcare offering in the future."

For further information, please visit:
http://www.dhcl.org

Digital healthcare is a holistic term incorporating telemedicine, telehealth, telecare, E-Health, M-Health, Health IT and Assisted Living. As aging populations, lifestyle related diseases and other social and economic drivers continue to dominate global healthcare systems, digital healthcare is rapidly emerging as a key solution for delivering sustainable health and care for the future.

D Health is a specialist consultancy which provides support services to the global digital healthcare community. Combined, D Health’s core team has over 70 years of experience in healthcare as academics, public servants, industry professionals and business leaders. Calling on its industry experience and networks, D Health’s expertise lies in its ability to identify funding, provide market intelligence, scope opportunities, design business/service models and broker partnerships.

The D Health Catalyst is a market accelerator programme that aims to work with leading organisation from the UK and Europe to drive rapid development of the digital healthcare market. D Health aims to stimulate interaction and development by ensuring the Catalyst represents a full cross-section of the market, from SMEs and blue chip companies to state providers and investors. By achieving this, Catalyst members can work in true collaboration, giving them new insight whilst reducing risk, thereby providing a competitive edge.

Most Popular Now

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...